Target- |
Mechanism- |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Mesothelin SS-(dsFv)-PE38(National Cancer Institute) | Mesothelioma More | Discontinued |
NPS-3 | Dermatitis More | Pending |
NPB-1 | Diabetes Mellitus, Type 2 More | Pending |
NPB-2 | Neoplasms More | Pending |
NP-003 (NeoPharm) ( PAR-2 ) | Dermatitis, Atopic More | Pending |